52 related articles for article (PubMed ID: 28646331)
21. Is CT or FDG-PET more useful for evaluation of the treatment response in metastatic HER2-positive breast cancer? a case report and literature review.
Suto H; Inui Y; Okamura A
Front Oncol; 2023; 13():1158797. PubMed ID: 37152012
[TBL] [Abstract][Full Text] [Related]
22. PET/CT-based radiomics analysis may help to predict neoadjuvant chemotherapy outcomes in breast cancer.
Yang L; Chang J; He X; Peng M; Zhang Y; Wu T; Xu P; Chu W; Gao C; Cao S; Kang S
Front Oncol; 2022; 12():849626. PubMed ID: 36419895
[TBL] [Abstract][Full Text] [Related]
23. PET-Derived Radiomics and Artificial Intelligence in Breast Cancer: A Systematic Review.
Urso L; Manco L; Castello A; Evangelista L; Guidi G; Castellani M; Florimonte L; Cittanti C; Turra A; Panareo S
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362190
[TBL] [Abstract][Full Text] [Related]
24. Radiomics in Oncological PET Imaging: A Systematic Review-Part 1, Supradiaphragmatic Cancers.
Morland D; Triumbari EKA; Boldrini L; Gatta R; Pizzuto D; Annunziata S
Diagnostics (Basel); 2022 May; 12(6):. PubMed ID: 35741138
[TBL] [Abstract][Full Text] [Related]
25. Multiparametric
Umutlu L; Kirchner J; Bruckmann NM; Morawitz J; Antoch G; Ting S; Bittner AK; Hoffmann O; Häberle L; Ruckhäberle E; Catalano OA; Chodyla M; Grueneisen J; Quick HH; Fendler WP; Rischpler C; Herrmann K; Gibbs P; Pinker K
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406499
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Value of Metabolic, Volumetric and Textural Parameters of Baseline [
Bouron C; Mathie C; Seegers V; Morel O; Jézéquel P; Lasla H; Guillerminet C; Girault S; Lacombe M; Sher A; Lacoeuille F; Patsouris A; Testard A
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158904
[TBL] [Abstract][Full Text] [Related]
27. Application of a Machine Learning Approach for the Analysis of Clinical and Radiomic Features of Pretreatment [
Nakajo M; Jinguji M; Tani A; Kikuno H; Hirahara D; Togami S; Kobayashi H; Yoshiura T
Mol Imaging Biol; 2021 Oct; 23(5):756-765. PubMed ID: 33763816
[TBL] [Abstract][Full Text] [Related]
28. A Systematic Review of PET Textural Analysis and Radiomics in Cancer.
Piñeiro-Fiel M; Moscoso A; Pubul V; Ruibal Á; Silva-Rodríguez J; Aguiar P
Diagnostics (Basel); 2021 Feb; 11(2):. PubMed ID: 33672285
[TBL] [Abstract][Full Text] [Related]
29. A priori prediction of tumour response to neoadjuvant chemotherapy in breast cancer patients using quantitative CT and machine learning.
Moghadas-Dastjerdi H; Sha-E-Tallat HR; Sannachi L; Sadeghi-Naini A; Czarnota GJ
Sci Rep; 2020 Jul; 10(1):10936. PubMed ID: 32616912
[TBL] [Abstract][Full Text] [Related]
30. Significance of Metabolic Tumor Volume at Baseline and Reduction of Mean Standardized Uptake Value in
Higuchi T; Fujimoto Y; Ozawa H; Bun A; Fukui R; Miyagawa Y; Imamura M; Kitajima K; Yamakado K; Miyoshi Y
Ann Surg Oncol; 2019 Jul; 26(7):2175-2183. PubMed ID: 30941655
[TBL] [Abstract][Full Text] [Related]
31. Radiomics analysis of pre-treatment [
van Helden EJ; Vacher YJL; van Wieringen WN; van Velden FHP; Verheul HMW; Hoekstra OS; Boellaard R; Menke-van der Houven van Oordt CW
Eur J Nucl Med Mol Imaging; 2018 Dec; 45(13):2307-2317. PubMed ID: 30094460
[TBL] [Abstract][Full Text] [Related]
32. Early Metabolic Response to Neoadjuvant Treatment: FDG PET/CT Criteria according to Breast Cancer Subtype.
Groheux D; Majdoub M; Sanna A; de Cremoux P; Hindié E; Giacchetti S; Martineau A; de Roquancourt A; Merlet P; Visvikis D; Resche-Rigon M; Hatt M; Espié M
Radiology; 2015 Nov; 277(2):358-71. PubMed ID: 25915099
[TBL] [Abstract][Full Text] [Related]
33. ¹⁸F-FDG PET/CT in the early prediction of pathological response in aggressive subtypes of breast cancer: review of the literature and recommendations for use in clinical trials.
Groheux D; Mankoff D; Espié M; Hindié E
Eur J Nucl Med Mol Imaging; 2016 May; 43(5):983-993. PubMed ID: 26758726
[TBL] [Abstract][Full Text] [Related]
34. MRI and PET/CT for evaluation of the pathological response to neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis.
Li H; Yao L; Jin P; Hu L; Li X; Guo T; Yang K
Breast; 2018 Aug; 40():106-115. PubMed ID: 29758503
[TBL] [Abstract][Full Text] [Related]
35. Textural features of
Cheng L; Zhang J; Wang Y; Xu X; Zhang Y; Zhang Y; Liu G; Cheng J
Ann Nucl Med; 2017 Aug; 31(7):544-552. PubMed ID: 28646331
[TBL] [Abstract][Full Text] [Related]
36. 18F-fluorodeoxyglucose (FDG) PET/CT after two cycles of neoadjuvant therapy may predict response in HER2-negative, but not in HER2-positive breast cancer.
Cheng J; Wang Y; Mo M; Bao X; Zhang Y; Liu G; Zhang J; Geng D
Oncotarget; 2015 Oct; 6(30):29388-95. PubMed ID: 26336821
[TBL] [Abstract][Full Text] [Related]
37.
Groheux D; Martineau A; Teixeira L; Espié M; de Cremoux P; Bertheau P; Merlet P; Lemarignier C
Breast Cancer Res; 2017 Jan; 19(1):3. PubMed ID: 28057031
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
